Targeting Α-Synuclein & Neuroinflammation In Parkinson's Disease

Targeting α-synuclein & neuroinflammation in Parkinson's disease

Assessing the efficacy of antibodies targeting α-synuclein

Targeting α-synuclein as a therapy for Parkinson’s disease: strategies in the pipeline

Investigating α-synuclein aggregation as a therapeutic target in Parkinson’s disease

Is α-synuclein a useful therapeutic target in Parkinson's disease?

Webinar - Clinical trials targeting alpha-synuclein

Cure Parkinson's

Detecting and Targeting Alpha Synuclein

Alpha-synuclein inhibitors, kinase inhibitors & targeting mitochondria in Parkinson’s disease

Therapeutic approaches to target alpha-synuclein in Parkinson’s disease

Alpha Synuclein Aggregates Targeting by Free-floating IFA | Protocol Preview

JoVE (Journal of Visualized Experiments)

Synapse with accumulating alpha-synuclein fibres

Is α-synuclein aggregation a cause or consequence of Parkinson’s disease?

Alpha-synuclein as a therapeutic target for Parkinson's disease

Parkinson’s Disease: Current Status and Potential Role of Emerging Agents Targeting Alpha-Synuclein

Misfolded alpha synuclein protein key to early detection of Parkinson’s disease Study

Medical Dialogues

Alpha-Synuclein fibres

Parkinson’s disease : alpha-synuclein, a major factor ?

France Parkinson

α-synuclein & Parkinson's disease: moving away from anti-α-synuclein approaches?

Detecting and Targeting Alpha Synuclein: Are We on a Path Toward a Cure for Parkinson's?

Movement Disorders Foundation of Arizona

Alpha-synuclein as a therapeutic target for Parkinson’s disease: challenges and opportunities